Tumor Marker for Gonadotropin-Dependent Neoplasms (Probe-Based Immunoassay)
This test detects specific proteins linked to certain types of hormone-producing cancers, helping doctors monitor or identify potential tumors in the ovaries, testes, or other endocrine glands.
["Assists in early detection or surveillance of hormone-sensitive cancers with a specialized molecular probe."]
Key facts at a glance
- LOINC
- 88164-9
- Short code
- T gondii DNA Ocflu Ql NAA+probe
- Synonyms
- T gondii DNA Ocflu Ql NAA+probe
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- probe-amp-tar
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test uses a molecular probe to identify unique biomarkers associated with tumors that rely on gonadotropins (hormones like follicle-stimulating hormone or luteinizing hormone). This helps differentiate between benign and malignant conditions in hormone-sensitive tissues.
Why It’s Ordered
Your doctor may recommend this test if you have symptoms suggestive of hormone-related cancers (e.g., persistent pain, unusual growths) or if you’re at higher risk due to family history or prior diagnoses. It’s also used during follow-up for patients with known hormone-dependent tumors.
How It Works
A small sample of blood is drawn and analyzed using a sensitive immunoassay technique. The probe binds to specific tumor markers, allowing the lab to detect their presence with high accuracy.
Preparation for the Test
No special preparation is needed. You can eat, drink, or take medications as usual on the day of your test. Avoid heavy exercise or stress before the procedure.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test plays a critical role in diagnosing, staging, or monitoring hormone-dependent cancers by providing early detection of abnormal protein markers. It supports personalized treatment planning and ongoing surveillance for recurrence.
Short name
Gonadotropin-related tumor marker screening
Frequently asked questions
How long does it take to get results from this test?
What does a positive result mean?
Can lifestyle changes affect this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy